Record overview
Status and phase
Status: COMPLETED
Phase: PHASE2
Sponsor: Australian and New Zealand Urogenital and Prostate Cancer Trials Group
Condition: Cancer of the Prostate, Metastatic Cancer
NCT03392428
A Trial of 177Lu-PSMA617 Theranostic Versus Cabazitaxel in Progressive Metastatic Castration Resistant Prostate Cancer
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Low Signal
Timeline signals: stale_update_signal
Results signal: Completed No Results Found Signal
Operational burden: large_enrollment_target_signal | rare_population_signal | strict_eligibility_signal
Stopped reason
Context when available
No stop reason available in the current public record.